Anti-Human CD279 Recombinant Antibody(Pidilizumab)

Product Information

Catalog Number	YR1298
Product Name	Anti-Human CD279 Recombinant Antibody(Pidilizumab)
Molecular Name	Pidilizumab
Alias	Anti-CD279 Recombinant Antibody, Research Grade Pidilizumab
CAS Number	1036730-42-3
Target	CD279[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Pidilizumab (formerly CT-011) is a monoclonal antibody being developed by Medivation for the treatment of cancer and infectious diseases. Pidilizumab was originally thought to bind to the PD-1 immune checkpoint molecule, however, recent evidence suggests that Delta-like 1 (DLL1) is its primary binding target while binding to PD-1 is secondary and restricted to non-glycosylated and hypoglycosylated forms of this molecule.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price